Mylan wins U.S. approval for Zoloft generic
NEW YORK |
NEW YORK (Reuters) - Mylan Laboratories Inc. MYL.N said on Tuesday it won U.S. approval for its generic versions of Pfizer Inc.'s (PFE.N) blockbuster anti-depressant Zoloft.
Mylan said it would ship its product immediately. Zoloft's generic name is sertraline hydrochloride.
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters